Cargando…

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card

Multiple rapid antigen (Ag) tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have recently received emergency-use authorization (EUA) from the U.S. Food and Drug Administration (FDA). Although less sensitive than molecular detection methods, rapid antigen testing offers the pot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perchetti, Garrett A., Huang, Meei-Li, Mills, Margaret G., Jerome, Keith R., Greninger, Alexander L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Virology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106729/ https://www.ncbi.nlm.nih.gov/pubmed/33310764 http://dx.doi.org/10.1128/JCM.02880-20

Ejemplares similares

Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting
por: Okoye, Nkemakonam C., et al.
Publicado: (2021)

Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020
por: Almendares, Olivia, et al.
Publicado: (2022)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Accuracy of Expired BinaxNOW Rapid Antigen Tests
por: Vaeth, Mary Jane E., et al.
Publicado: (2023)

Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2
por: Mai, Yue-Xue, et al.
Publicado: (2023)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population
por: Pollreis, Rachel E., et al.
Publicado: (2021)

The BinaxNOW pneumococcal antigen test: An adjunct for diagnosis of pneumococcal bacteraemia
por: Tootla, Hafsah D., et al.
Publicado: (2021)

Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers
por: Beraud, L., et al.
Publicado: (2015)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration
por: Frediani, Jennifer K., et al.
Publicado: (2021)

Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA
por: Surasi, Krishna, et al.
Publicado: (2021)

Comparison of a Prototype SARS-CoV-2 Lateral Flow IMMUNOASSAY with the BinaxNOW(TM) COVID-19 Antigen CARD
por: Hill, Haydon J., et al.
Publicado: (2022)

Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit
por: Nalla, Arun K., et al.
Publicado: (2020)

Comparison of the ImmuView and the BinaxNOW antigen tests in detection of Streptococcus pneumoniae and Legionella pneumophila in urine
por: Athlin, S., et al.
Publicado: (2017)

366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers
por: Surasi, Krishna, et al.
Publicado: (2021)

Performance of BinaxNOW G6PD Deficiency Point-of-Care Diagnostic in P. vivax-Infected Subjects
por: Osorio, Lyda, et al.
Publicado: (2015)

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening
por: Stokes, Nadarra L., et al.
Publicado: (2021)

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020
por: Prince-Guerra, Jessica L., et al.
Publicado: (2021)

High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site during Prevalent Delta Variant Period
por: Sun, Kristie J., et al.
Publicado: (2022)

Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories
por: Lieberman, Joshua A., et al.
Publicado: (2020)

Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test
por: Mokhtari, Camelia, et al.
Publicado: (2016)

Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs
por: Landaverde, Lena, et al.
Publicado: (2022)

Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
por: Basu, Atreyee, et al.
Publicado: (2020)

Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site
por: Siddiqui, Zishan K., et al.
Publicado: (2021)

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
por: Addetia, Amin, et al.
Publicado: (2020)

Verification and Validation of SARS-CoV-2 Assay Performance on the Abbott m2000 and Alinity m Systems
por: Hirschhorn, Julie W., et al.
Publicado: (2021)

SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests
por: Nguyen, Phuong-Vi, et al.
Publicado: (2023)

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
por: Schrom, John, et al.
Publicado: (2023)

Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence
por: Jonathan, Nteimam
Publicado: (2006)

Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance
por: Degli-Angeli, Emily, et al.
Publicado: (2020)

Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires’ disease or pneumococcal pneumonia and meningitis
por: Edelstein, Paul H., et al.
Publicado: (2020)

Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors
por: Dalmat, Ronit R., et al.
Publicado: (2018)

Copy Number Heterogeneity of JC Virus Standards
por: Greninger, Alexander L., et al.
Publicado: (2017)

Establishing conditions for the storage and elution of rabies virus RNA using FTA(®) cards
por: SAKAI, Takeo, et al.
Publicado: (2014)

Impact of SARS-CoV-2 Variants on the Analytical Sensitivity of rRT-PCR Assays
por: Chen, Yuqing, et al.
Publicado: (2022)

Rapid Metagenomic Next-Generation Sequencing during an Investigation of Hospital-Acquired Human Parainfluenza Virus 3 Infections
por: Greninger, Alexander L., et al.
Publicado: (2016)

Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests
por: Payne, David, et al.
Publicado: (2023)

Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rvo6mru9h8olcesjla38g5m725